1. Moscho, A. et al. Deals that make sense. Nat. Biotechnol. 18, 719–722 (2000).
2. US Congress, Office of Technology Assessment. Pharmaceutical R&D: costs, risks and rewards, OTA-H-522. (US Government Printing Office, Washington, DC; February 1993).
3. PhRMA. The pharmaceutical industry profile 2000. Pharmaceutical Research and Manufacturers of America.
http://www.phrma.org/publications/publications/profile00/
4. US Food and Drug Information Office of Planning. FY 2000 Performance Report to Congress for the Prescription Drug User Fee Act of 1992 as reauthorized and amended by the Food and Drug Administration Modernization Act of 1997 (2001).
http://www.fda.gov/ope/pdufa/report2000/default.htm